Mammographic density and the risk of breast cancer recurrence after breast-conserving surgery

Tulin CilDavid R McCready


Women with invasive breast cancer who are treated with breast-conserving surgery and radiotherapy face a cumulative risk of local disease recurrence of approximately 10% at 10 years. To the authors' knowledge, the role of mammographic density as a risk factor for the development of local recurrence has not been thoroughly evaluated to date. Medical records were reviewed for 335 patients who underwent breast-conserving surgery for invasive breast cancer and for whom a pretreatment mammogram was available. Information was recorded concerning mammographic density as well as tumor features, patient characteristics, and adjuvant treatments received. Patients were categorized for mammographic density based on the Wolfe classification as either low (<25% density), intermediate (25-50% density), or high (>50% density). A multivariate survival analysis was conducted using the Cox proportional hazards model with local disease recurrence as the primary endpoint. Patients in the high mammographic density group experienced a much greater risk of local disease recurrence compared with women with the least dense breasts (10-year actuarial risks: 21% vs 5%; hazards ratio [HR], 5.7 [95% confidence interval, 1.6-20; P=.006]). The difference in t...Continue Reading


Jan 1, 1987·Epidemiologic Reviews·A F Saftlas, M Szklo
Jun 1, 1986·International Journal of Radiation Oncology, Biology, Physics·R CalleA Fourquet
Feb 1, 1982·British Journal of Cancer·N F BoydT Germanson
Jan 1, 1993·Epidemiologic Reviews·A M Oza, N F Boyd
Aug 5, 1998·European Journal of Epidemiology·C H van GilsJ H Hendriks
Sep 13, 2000·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·J M ChanM Pollak
Mar 17, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A C VoogdUNKNOWN Danish Breast Cancer Cooperative Group. Breast Cancer Cooperative Group of the European Organization for Research and Treatm
Aug 28, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R ArriagadaM Spielmann
Apr 22, 2004·Journal of the National Cancer Institute·Jack CuzickStephen W Duffy
Oct 7, 2004·Journal of the National Cancer Institute·Laurel A HabelThomas B Julian
Nov 25, 2004·Technology in Cancer Research & Treatment·Jennifer A Harvey
Oct 4, 2005·The Lancet Oncology·Norman F BoydAndrew D Paterson
Jan 19, 2007·The New England Journal of Medicine·Norman F BoydMartin J Yaffe
Apr 29, 2008·Nature Medicine·Greg FinakMorag Park
Aug 12, 2008·International Journal of Radiation Oncology, Biology, Physics·Catherine C ParkKarla Kerlikowske

❮ Previous
Next ❯


Jul 1, 1995·Journal of Clinical Epidemiology·L BucchiP Bruzzi
Mar 17, 1984·Lancet·A L VerbeekF Sturmans
Mar 16, 2001·Academic Radiology·R SivaramakrishnaK A Powell
Jun 27, 2012·Nature Reviews. Clinical Oncology·Steven A Narod
Oct 7, 2004·Journal of the National Cancer Institute·Laurel A HabelThomas B Julian
Aug 23, 2012·Journal of the National Cancer Institute·Gretchen L GierachMark E Sherman
Jul 1, 2005·Breast Cancer Research : BCR·Rulla M TamimiGraham A Colditz
Sep 20, 2005·Breast Cancer Research : BCR·Giske UrsinAnna H Wu
Nov 26, 2011·Breast Cancer Research : BCR·Norman F BoydSalomon Minkin
Jan 24, 2013·Breast Cancer Research : BCR·Gertraud MaskarinecLaurence N Kolonel
Jul 13, 2013·Breast Cancer Research : BCR·Louise ErikssonPer Hall
Jul 24, 2013·Breast Cancer Research : BCR·Maria E C SandbergKamila Czene
Sep 7, 2013·Breast Cancer Research : BCR·Hilda RazzaghiRobert C Millikan
Aug 21, 2004·Breast Cancer Research : BCR·Mehrdad HaririRama Khokha
Oct 1, 2010·Annals of Surgical Oncology·Nimmi AroraMonica Morrow
Sep 4, 2012·Annals of Surgical Oncology·Nimmi S KapoorMonica Morrow
Aug 10, 2012·Current Oncology·S A Narod, S A Narod
Feb 5, 2014·Nature Reviews. Clinical Oncology·Steven A Narod
Mar 13, 2010·Future Oncology·Gertraud MaskarinecLaurence N Kolonel
Mar 13, 2014·Breast Cancer Research and Treatment·C W HuoE W Thompson
Jul 12, 2014·Medical Oncology·Shereef ElsamanyFeras K Olayan
Sep 25, 2014·Journal of Pathology Informatics·Jeremy S BredfeldtKevin W Eliceiri
Mar 8, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Celine M VachonJames N Ingle
Jun 15, 2015·The Breast : Official Journal of the European Society of Mastology·S ElsamanyN M Abdel-Aziz
Feb 19, 2015·Menopause : the Journal of the North American Menopause Society·Lucy Ann BehanRobert F Casper
Sep 25, 2016·Proceedings of the National Academy of Sciences of the United States of America·Weijing HanLiyu Liu
Jun 10, 2019·Breast Cancer Research and Treatment·Michael S ShawkyErik W Thompson
Jan 20, 2016·Oncotarget·Alastair J Ironside, J Louise Jones
Aug 23, 2019·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Matthew C JonesMartin J Humphries
Oct 12, 2010·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Laurel A HabelCharles P Quesenberry
Dec 30, 2020·Cancer Epidemiology·M PizzatoC La Vecchia

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Hereditary Sensory Autonomic Neuropathy

Hereditary Sensory Autonomic Neuropathies are a group of inherited neurodegenerative disorders characterized clinically by loss of sensation and autonomic dysfunction. Here is the latest research on these neuropathies.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Landau-Kleffner Syndrome

Landau Kleffner syndrome (LKS), also called infantile acquired aphasia, acquired epileptic aphasia, or aphasia with convulsive disorder, is a rare childhood neurological syndrome characterized by the sudden or gradual development of aphasia (the inability to understand or express language) and an abnormal electroencephalogram. Discover the latest research on LKS here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.